Search results
Results from the WOW.Com Content Network
IBA GROUP is an international IT company founded in 1993. [ 1 ] [ 2 ] The company’s focus areas include enterprise applications, mainframe systems, SAP solutions, cloud technologies, and RPA/ML/AI solutions.
IBA has developed an affinity chromatography system for non-magnetic isolation of peripheral blood mononuclear cells, T cells, B cells and other cells of interest. This technology is known as Fab-TACS (Traceless Affinity Cell Selection) and is based on Strep-tagged Fab fragments, which reversibly capture and release the target cells.
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. [1] [2] [3] It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), [4] and changed its name to the Biotechnology Innovation ...
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Ibalizumab is being developed by TaiMed Biologics but was originally developed by Tanox, now part of Genentech.As part of Genentech's takeover of Tanox, the patent for ibalizumab was sold to TaiMed Biologics, a biotech company formed in 2007 with support from the Taiwanese Government through a $20 million investment by the state-owned National Development Fund.
2006: ICON acquired outcomes research and health economics specialist, Ovation Research Group [24] 2007: ICON acquired European staffing group, DOCS International [25] 2008: ICON acquired US phase I provider, Healthcare Discoveries and US bioanalytical lab, Prevalere Life Sciences [26] [27] 2009: ICON acquired Veeda Laboratories, a UK biomarker ...
More than 25 million people lost coverage during the “unwinding” of Medicaid— the majority for procedural reasons like paperwork issues, according to the health policy research group KFF.
The Group's businesses include CSL Vifor, focused on iron deficiency and iron deficiency anaemia, and Vifor Fresenius Medical Care Renal Pharma, focused on kidney disease patients, including anaemia, mineral and bone management, cardio-renal conditions, and rare diseases. [23]